Immunic (IMUX) Return on Capital Employed Growth (3y) (2017 - 2026)
Immunic (IMUX) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Immunic |
384.84 Mn |
198.21 Mn |
- |
-3,714.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-3,714.00 |
| Dec 31, 2025 |
-575,791.00 |
| Sep 30, 2025 |
-43,196.00 |
| Jun 30, 2025 |
-70,930.00 |
| Mar 31, 2025 |
-191,985.00 |
| Dec 31, 2024 |
-25,287.00 |
| Sep 30, 2024 |
-12,134.00 |
| Jun 30, 2024 |
-6,833.00 |
| Mar 31, 2024 |
-11,233.00 |
| Dec 31, 2023 |
-24,597.00 |
| Sep 30, 2023 |
-18,626.00 |
| Jun 30, 2023 |
-10,121.00 |
| Mar 31, 2023 |
-4,799.00 |
| Dec 31, 2022 |
-4,529.00 |
| Sep 30, 2022 |
-1,682.00 |
| Jun 30, 2022 |
818.00 |
| Mar 31, 2022 |
7,630.00 |
| Dec 31, 2021 |
9,684.00 |
| Sep 30, 2021 |
9,354.00 |
| Jun 30, 2021 |
7,616.00 |
